Apurva Biosciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.19 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 15.95 Cr
About Apurva Biosciences
Apurva Biosciences Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 February 2010 and has a history of 14 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.19 M.
The company currently has active open charges totaling ₹15.95 Cr.
Sheetal Ranaut, Sambhaji Varne, and Hemangini Varne serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2010PTC200324
-
Company No.
200324
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2010
-
Date of AGM
29 Sep 2012
-
Date of Balance Sheet
31 Mar 2012
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Apurva Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheetal Ranaut
|
Director | 22-Feb-2010 | Current |
|
Sambhaji Varne
|
Director | 22-Feb-2010 | Current |
|
Hemangini Varne
|
Director | 22-Feb-2010 | Current |
Financial Performance of Apurva Biosciences.
Enhance accessibility to Apurva Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apurva Biosciences?
Unlock access to Apurva Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Apurva Biopharm Private LimitedSheetal Ranaut and Sambhaji Varne are mutual person
Charges (Loans)
₹15.95 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 15.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2011 | State Bank Of India | ₹15.95 Cr | Open |
How Many Employees Work at Apurva Biosciences?
Unlock and access historical data on people associated with Apurva Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apurva Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apurva Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.